Bile Acid Uptake Transporters as Targets for Therapy
Related Experiment Video
Updated: Mar 7, 2026

Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport
Published on: November 27, 2016
Davor Slijepcevic1, Stan F J van de Graaf
1Tytgat Institute for Liver and Intestinal Research, Academic Medical Center, Amsterdam, The Netherlands.
Background:
Bile acids are potent signaling molecules that regulate glucose, lipid and energy homeostasis predominantly via the bile acid receptors farnesoid X receptor (FXR) and transmembrane G protein-coupled receptor 5 (TGR5). The sodium taurocholate cotransporting polypeptide (NTCP) and the apical sodium dependent bile acid transporter (ASBT) ensure an effective circulation of (conjugated) bile acids. The modulation of these transport proteins affects bile acid localization, dynamics and signaling. The NTCP-specific pharmacological inhibitor myrcludex B inhibits hepatic uptake of conjugated bile acids. Multiple ASBT-inhibitors are already in clinical trials to inhibit intestinal bile acid uptake. Here, we discuss current insights into the consequences of targeting bile acid uptake transporters on systemic and intestinal bile acid dynamics and discuss the possible therapeutic applications that evolve as a result.
Insights
Targeting bile acid transporters impacts glucose, lipid, and energy balance. Inhibiting uptake via NTCP or ASBT offers potential therapeutic strategies for metabolic homeostasis.
Area of Science:
- Endocrinology and Metabolism
- Hepatology
- Gastroenterology
Background:
- Bile acids are crucial signaling molecules regulating glucose, lipid, and energy homeostasis.
- They exert effects via farnesoid X receptor (FXR) and TGR5 signaling pathways.
- Bile acid transporters, including NTCP and ASBT, are key to bile acid circulation and signaling.
Purpose of the Study:
- To review current understanding of targeting bile acid uptake transporters.
- To explore the impact on systemic and intestinal bile acid dynamics.
- To discuss emerging therapeutic applications.
Main Methods:
- Literature review and synthesis of current research findings.
- Analysis of pharmacological interventions targeting bile acid transporters.
- Discussion of clinical trial data for ASBT inhibitors.
Main Results:
- Modulation of NTCP and ASBT affects bile acid localization, dynamics, and signaling.
- NTCP inhibition (e.g., myrcludex B) impacts hepatic bile acid uptake.
- ASBT inhibitors are in clinical trials for modulating intestinal bile acid uptake.
Conclusions:
- Targeting bile acid uptake transporters presents a promising therapeutic avenue.
- Understanding transporter modulation is key to optimizing metabolic regulation.
- Further research into systemic and intestinal bile acid dynamics is warranted for therapeutic development.
More Related Videos
09:21Real Time Monitoring of Intracellular Bile Acid Dynamics Using a Genetically Encoded FRET-based Bile Acid Sensor
Published on: January 4, 2016
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
Related Concept Videos
Hepatic Drug Clearance: Role of Transporters
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
ABC Transporters: Importer
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
Bioavailability Enhancement: Drug Permeability Enhancement
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
ABC Transporters: Exporter